PMID: 9442989Jan 27, 1998Paper

The evaluation of fee for service and managed care from the viewpoint of people with disabilities in the USA

Disability and Rehabilitation
R BeineckeN Soussou

Abstract

In the literature on managed health care there is little presented from the viewpoint of people with disabilities, but this study looks at what is found. Using a sample of 258 persons with disabilities in Massachusetts obtained through a mail survey, no statistically significant differences between the two groups (fee for service or managed care) on a series of relevant variables was found. An evaluation of their health insurance and their primary care physician was asked for and several regression models of the relevant variables related to these two evaluations were tested. It seems that accessibility of the primary care physicians's office and the physician's level of understanding of the person's disability are related in a statistically significant way to their rating of their health insurance. Also it appears that the ease of obtaining an appointment and the physician's level of understanding of the person's disability are related in a statistically significant way to the evaluation of their primary care physician. The major policy implication of these findings is that managed care may not be the disaster which many foresee it to be.

References

Jan 1, 1992·Journal of Health Politics, Policy and Law·A Brotman
May 1, 1988·QRB. Quality Review Bulletin·R A Kane
Jul 1, 1995·Psychiatric Services : a Journal of the American Psychiatric Association·S A PickettS I Miller
Jan 1, 1995·Journal of Health Politics, Policy and Law·T Skocpol
Jan 1, 1995·Health Affairs·K DavisC Morris
Apr 1, 1995·The American Journal of Nursing·T Neumann, W Ruga
Oct 26, 1994·JAMA : the Journal of the American Medical Association·E L BakerD Satcher
Mar 2, 1995·The New England Journal of Medicine·M A Rodwin
Jan 1, 1994·Journal of Health Care for the Poor and Underserved·A L Jackson
Aug 1, 1994·The Journal of School Health·J S PalfreyM L Cammisa
Jan 1, 1994·International Journal of Health Services : Planning, Administration, Evaluation
May 1, 1994·Academic Medicine : Journal of the Association of American Medical Colleges·R S Fisher
May 7, 1994·BMJ : British Medical Journal·R J GreenwoodJ R Price
May 25, 1994·JAMA : the Journal of the American Medical Association·D G SafranW H Rogers
Jan 1, 1993·Journal of Health Politics, Policy and Law·L R Jacobs
Feb 1, 1996·American Journal of Public Health·D P AndrulisR J Anderson
Jan 1, 1995·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·K T Christensen
Jan 1, 1995·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·W K Mariner
Jan 1, 1995·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·S H Johnson
Dec 9, 1994·The Journal of Ambulatory Care Management·J G ZapkaC K Warner
Apr 1, 1996·Journal of Policy Analysis and Management : [the Journal of the Association for Public Policy Analysis and Management]·A R Kovner

❮ Previous
Next ❯

Citations

Jul 10, 2002·The Milbank Quarterly·Gerben DejongMelinda T Neri
Feb 19, 2004·Archives of Physical Medicine and Rehabilitation·Andrew I Batavia, Mitchell Batavia
Oct 31, 2003·Archives of Physical Medicine and Rehabilitation·Phillip W BeattyShelley A Hilton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved